ArcherDx will develop in vitro diagnostic tests, including companion diagnostics, to run on Illumina's NextSeq 550Dx next-generation sequencing system.
The platform matches a patient's medical history and other data with national guidelines to recommended medically actionable genetic tests.
Of the 28 companies in the index, 21 companies' share prices increased while the share values of 7 declined month over month.
The Genetron Health S5 NGS system is based on the Thermo Fisher Scientific Ion GeneStudio S5 and will be accompanied by Genetron-developed assays.
Yourgene said it continues to consider additional acquisition opportunities to enhance its earnings and to acquire complementary technologies.
Microbiology lab and industry stakeholders are increasingly working together to coordinate approaches and generate more clinical utility data for diagnostic testing.
The companies gained FDA approval for the Liaison QuantiFeron-TB Plus Test, an automated workflow and assay for latent tuberculosis detection.
Called Ion, the system combines low magnification, high-resolution imaging with a proprietary image analysis algorithm for rapid pathogen detection.
The owner is accused of falsely billing Medicare for cancer genomic testing and pharmacogenetic testing that regularly exceeded $12,000 per beneficiary.
A federal jury found Roche Diagnostics infringed multiple claims on several patents covering Meso Scale's electrochemiluminescence technology.